A review of recent findings suggests that Appili's biodefense vaccine, ATI-1701, may have a role in preventing tularemia ...

Verastem Oncology , a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced that its management team is scheduled to ...

QbDVision® Inc., the leading Digital CMC platform (Chemistry, Manufacturing, and Controls) for the life sciences industry, today announced the close of $13 million in new financing, bringing the total ...

Aquaron Acquisition Corp. ("Aquaron” or the "Company”) (OTCMKTS: AQUC), a publicly traded special purpose acquisition company, today announced that its Annual Meeting of Stockholders (the "Annual ...